[HTML][HTML] New insights into the complex role of mitochondria in Parkinson's disease

A Grünewald, KR Kumar, CM Sue - Progress in neurobiology, 2019 - Elsevier
New discoveries providing insights into mitochondrial bioenergetics, their dynamic
interactions as well as their role in cellular homeostasis have dramatically advanced our …

[HTML][HTML] Monogenic Parkinson's disease: genotype, phenotype, pathophysiology, and genetic testing

F Jia, A Fellner, KR Kumar - Genes, 2022 - mdpi.com
Genes | Free Full-Text | Monogenic Parkinson’s Disease: Genotype, Phenotype,
Pathophysiology, and Genetic Testing Next Article in Journal enChIP-Seq Analyzer: A …

[HTML][HTML] Next generation sequencing and the future of genetic diagnosis

K Lohmann, C Klein - Neurotherapeutics, 2014 - Elsevier
The introduction of next generation sequencing (NGS) has led to an exponential increase of
elucidated genetic causes in both extremely rare diseases and common but heterogeneous …

Genetics of Parkinson disease

A Domingo, C Klein - Handbook of clinical neurology, 2018 - Elsevier
An understanding of the genetic etiology of Parkinson disease (PD) has become imperative
for the modern-day neurologist. Although genetic forms cause only a minority of PD, the …

PGC-1s in the Spotlight with Parkinson's Disease

E Piccinin, AM Sardanelli, P Seibel… - International journal of …, 2021 - mdpi.com
Parkinson's disease is one of the most common neurodegenerative disorders worldwide,
characterized by a progressive loss of dopaminergic neurons mainly localized in the …

The many faces of alpha‐synuclein mutations

M Kasten, C Klein - Movement Disorders, 2013 - Wiley Online Library
Since the first description of alpha‐synuclein (SNCA) mutations in 1997, this gene has
probably become the most intensely investigated one associated with monogenic Parkinson …

Neurodegenerative diseases: their onset, epidemiology, causes and treatment

S Zaib, H Javed, I Khan, F Jaber, A Sohail… - …, 2023 - Wiley Online Library
Neurodegenerative diseases are a group of diseases with several neuropathological
symptoms. Degenerative nerve diseases can be serious or life‐threatening. Because of the …

Paraoxonase 1 in neurological disorders

T Menini, A Gugliucci - Redox Report, 2014 - Taylor & Francis
Paroxonase 1 displays multiple physiological activities that position it as a putative player in
the pathogenesis of neurological disorders. Here we reviewed the literature focusing on the …

Potential neuroprotective activity of Ginseng in Parkinson's disease: a review

E González-Burgos, C Fernandez-Moriano… - Journal of Neuroimmune …, 2015 - Springer
Parkinson's disease is a chronic, multifactorial and progressive neurologic condition that
affects around six million people worldwide, normally over 60 years of age, and is …

Animal toxins as therapeutic tools to treat neurodegenerative diseases

JM De Souza, BDC Goncalves, MV Gomez… - Frontiers in …, 2018 - frontiersin.org
Neurodegenerative diseases affect millions of individuals worldwide. So far, no disease-
modifying drug is available to treat patients, making the search for effective drugs an urgent …